Slingshot members are tracking this event:
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam)
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
- Label now includes Phase 3 clinical data evaluating the safety and efficacy of AVYCAZ (in combination with metronidazole) in patients with complicated intra-abdominal infections (cIAI) -
Slingshot Insights Explained
Jun 23, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Avycaz, Snda, Ceftazidime, Avibactam, Beta-lactamases, Esbls, Metronidazole